Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Operating Expenses | 11,498 | 9,409 | 1,029 | 705 | 1,722 |
| Operating Income | -11,498 | -9,409 | -1,029 | -705 | -1,722 |
| Interest Expense | -1 | 0 | 104 | 342 | 1,596 |
| Other Income | 0 | 0 | -2,296 | 0 | 6,785 |
| Pre-tax Income | -11,497 | -9,409 | -3,429 | -1,047 | 3,466 |
| Net Income Continuous | -11,497 | -9,409 | -3,429 | -1,047 | 3,466 |
| Net Income | $-11,497 | $-9,409 | $-3,429 | $-1,047 | $3,466 |
| EPS Basic Total Ops | 2.66 | -0.66 | -4.19 | -1.28 | 4.11 |
| EPS Basic Continuous Ops | 3.53 | -0.66 | -4.19 | -1.28 | 4.53 |
| EPS Diluted Total Ops | 2.66 | -0.66 | -4.19 | -1.28 | 4.11 |
| EPS Diluted Continuous Ops | 3.53 | -0.66 | -4.19 | -1.28 | 4.53 |
| EBITDA(a) | $-11,941 | $-8,962 | $-1,028 | $-703 | $-1,721 |